Article
DADA2 as a Model of Monogenic Immune Vasculopathy: From Immunopathogenesis to Precision Therapeutics.
Biomolecules - 19 Jul 2026
Peng Hao, Li Chunxia, Mo Chune, Li Bihui, Ou Minglin
Abstract excerpt
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic autoinflammatory disorder caused by biallelic loss-of-function mutations in the ADA2 gene (formerly CECR1). First described in 2014, DADA2 has emerged as a paradigm for monogenic vasculitis, bridging the gap between primary immunodeficiencies and systemic vasculitides. The disease is characterized by a remarkably broad clinical spectrum encompassing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
